{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:01:30Z","timestamp":1769853690009,"version":"3.49.0"},"reference-count":116,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Cervical esophageal cancer (CEC) is an uncommon malignancy accounting for &lt;5% of all esophageal carcinomas. Treatment of CEC varies and is adapted from established regimens used for squamous cell carcinoma (SCC) or the lower esophageal and head and neck. The present systematic review and guidelines are intended to assist treatment decision making for patients with CEC based on the available evidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Using the Population, Intervention, Comparator, Outcome, Timing, and Study Design (PICOTS) framework, the evidence regarding treatment outcomes was assessed using Cochrane and PRISMA 2020 methodology. Eligible studies included prospective Phase II to III trials and retrospective analyses published between January 1, 2013 and February 23, 2024 in the Ovid Medline database. These references were assessed through the American Radium Society (ARS) Appropriate Use Criteria (AUC) methodology. A systematic review PRISMA 2020 checklist confirmed the completion of essential elements. RAND-UCLA consensus methodology was used by the expert panel to rate the appropriateness of the treatment options.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>ARS AUC recommendations include (1) larynx preservation using endoscopic resection (EMR or ESD) alone for the typical case with pT1a cN0 cM0 CEC, (2) definitive CRT for the typical case with cT1bN0M0 in patients who cannot undergo endoscopic resection, (3) larynx-preserving using definitive CRT (with or without induction chemotherapy) for the typical case with nonmetastatic locally advanced CEC (advanced T-stage tumors or involved lymph nodes), with surgery reserved for those patients with incomplete response or locoregional recurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This ARS AUC summary provides guidelines for the management of SCC of the cervical esophagus provides based on available evidence. Topics that warrant further investigation include optimization of (1) patient selection; (2) multimodality therapies including chemotherapy, immunotherapy, and targeted agents; (3) radiation dose, schedule, and treatment volume; and (4) supportive care for patients with CEC. Ongoing trials continue to improve outcomes for patients with CEC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000001165","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T11:02:07Z","timestamp":1738839727000},"page":"163-179","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus"],"prefix":"10.1097","volume":"48","author":[{"name":"Expert Panel Management of Cervical Esophageal Cancer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vonetta M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Hallemeier","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishan R.","family":"Jethwa","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Eva","family":"Selfridge","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, University Hospitals Cleveland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pari","family":"Shah","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, Memorial Sloan Kettering, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Anker","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard","family":"Abood","sequence":"additional","affiliation":[{"name":"Department of Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitriy","family":"Akselrod","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Vermont Larner College of Medicine, Burlington, VT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Berlin","sequence":"additional","affiliation":[{"name":"Division of Hematology Oncology, Department of Medicine Vanderbilt-Ingram Cancer Center, Nashville, TN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ed","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Surgery, Rutgers Cancer Institute, New Brunswick, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Percy","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, City of Hope National Medical Center, Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navesh","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, WellSpan Cancer Center, York, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Small","family":"William","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cardinal Bernardin Cancer Center, Loyola University Stritch School of Medicine, Maywood, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Tchelebi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4144-4711","authenticated-orcid":false,"given":"Suzanne","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, MetroHealth, Case Western Reserve University School of Medicine, Cleveland, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"R1-20250325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11912-019-0801-7","article-title":"Cervical esophageal cancers: challenges and opportunities","volume":"21","author":"Buckstein","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"R2-20250325","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.ijrobp.2017.12.073","article-title":"Cervical esophageal cancer: a comparison of outcomes by treatment paradigm, tumor location, and histology using the National Cancer Database","volume":"100","author":"Torgeson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-20250325","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R4-20250325","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R6-20250325","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R7-20250325","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.athoracsur.2013.02.069","article-title":"The Society of Thoracic Surgeons guidelines on the diagnosis and staging of patients with esophageal cancer","volume":"96","author":"Varghese","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R8-20250325","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1055\/s-2004-825802","article-title":"Histological analysis of endoscopic resection specimens from 326 patients with Barrett\u2019s esophagus and early neoplasia","volume":"36","author":"Vieth","year":"2004","journal-title":"Endoscopy"},{"key":"R9-20250325","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1067\/mge.2003.130","article-title":"Endoscopic mucosal resection","volume":"57","author":"Soetikno","year":"2003","journal-title":"Gastrointest Endosc"},{"key":"R10-20250325","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doab047","article-title":"Transition from esophagectomy to endoscopic therapy for early esophageal cancer","volume":"35","author":"Dunn","year":"2022","journal-title":"Dis Esophagus"},{"key":"R11-20250325","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1442-2050.2012.01370.x","article-title":"Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer","volume":"26","author":"Yoshii","year":"2013","journal-title":"Dis Esophagus"},{"key":"R12-20250325","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1038\/ctg.2017.36","article-title":"Efficacy and safety of endoscopic resection followed by chemoradiotherapy for superficial esophageal squamous cell carcinoma: a retrospective study","volume":"8","author":"Hamada","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"R13-20250325","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/01.pas.0000168175.63782.9e","article-title":"Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma","volume":"29","author":"Liu","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R14-20250325","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/SLA.0b013e31827017fc","article-title":"The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients","volume":"257","author":"Akutsu","year":"2013","journal-title":"Ann Surg"},{"key":"R15-20250325","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1245\/s10434-016-5138-y","article-title":"Outcomes of surgical resection of T1bN0 esophageal cancer and assessment of endoscopic mucosal resection for identifying low-risk cancers appropriate for endoscopic therapy","volume":"23","author":"Mohiuddin","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R16-20250325","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2013-305538","article-title":"Long-term recurrence of neoplasia and Barrett\u2019s epithelium after complete endoscopic resection","volume":"63","author":"Anders","year":"2014","journal-title":"Gut"},{"key":"R17-20250325","doi-asserted-by":"crossref","first-page":"529","DOI":"10.5152\/tjg.2020.19329","article-title":"Usefulness of argon plasma coagulation for superficial esophageal squamous cell neoplasia in patients at high risk or with limited endoscopic resectability","volume":"31","author":"Kubota","year":"2020","journal-title":"Turk J Gastroenterol"},{"key":"R18-20250325","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/jjco\/hyp078","article-title":"Gastrointestinal Oncology Study Group of Japan Clinical Oncology G. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508","volume":"39","author":"Kurokawa","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"R19-20250325","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4253\/wjge.v8.i20.763","article-title":"Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection","volume":"8","author":"Ballard","year":"2016","journal-title":"World J Gastrointest Endosc"},{"key":"R20-20250325","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/a-1811-7025","article-title":"Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022","volume":"54","author":"Pimentel-Nunes","year":"2022","journal-title":"Endoscopy"},{"key":"R21-20250325","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doaa081","article-title":"Efficacy and safety of endoscopic submucosal dissection versus endoscopic mucosal resection for superficial esophageal carcinoma: a systematic review and meta-analysis","volume":"34","author":"Han","year":"2021","journal-title":"Dis Esophagus"},{"key":"R22-20250325","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1308\/rcsann.2020.0177","article-title":"The safety and efficacy of endoscopic submucosal dissection for treating early oesophageal carcinoma: a meta-analysis","volume":"102","author":"Wang","year":"2020","journal-title":"Ann R Coll Surg Engl"},{"key":"R23-20250325","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.gie.2018.04.2360","article-title":"Comparison of endoscopic submucosal dissection and surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched analysis","volume":"88","author":"Min","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"R24-20250325","doi-asserted-by":"crossref","first-page":"e00193","DOI":"10.14309\/ctg.0000000000000193","article-title":"Endoscopic submucosal dissection versus surgery for superficial esophageal squamous cell carcinoma: a propensity score-matched survival analysis","volume":"11","author":"Lee","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"R25-20250325","first-page":"2977","article-title":"Endoscopic submucosal dissection versus esophagectomy for early esophageal squamous cell carcinoma with tumor invasion to different depths","volume":"10","author":"An","year":"2020","journal-title":"Am J Cancer Res"},{"key":"R26-20250325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3892\/etm.2023.11820","article-title":"Long\u2011term prognosis and comprehensive endoscopic treatment strategy for esophageal cancer, including salvage endoscopic treatment after chemoradiation therapy","volume":"25","author":"Shiota","year":"2023","journal-title":"Exp Ther Med"},{"key":"R27-20250325","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00464-022-09683-z","article-title":"Therapeutic strategies following endoscopic submucosal dissection for T1a-MM\/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis","volume":"37","author":"Li","year":"2023","journal-title":"Surg Endosc"},{"key":"R28-20250325","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gie.2005.09.027","article-title":"Histologic results of EMR for esophageal lesions diagnosed as high-grade intraepithelial squamous neoplasia by endoscopic biopsy","volume":"63","author":"Shimizu","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"R29-20250325","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/jgh.14571","article-title":"Histopathologic discrepancies between endoscopic forceps biopsy and endoscopic resection specimens in superficial esophageal squamous neoplasms","volume":"34","author":"Park","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R30-20250325","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000445221","article-title":"Endoscopic resection and radiofrequency ablation for early esophageal neoplasia","volume":"34","author":"Belghazi","year":"2016","journal-title":"Dig Dis"},{"key":"R31-20250325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1055\/s-0034-1391285","article-title":"Endoscopic radiofrequency ablation for early esophageal squamous cell neoplasia: report of safety and effectiveness from a large prospective trial","volume":"47","author":"He","year":"2015","journal-title":"Endoscopy"},{"key":"R32-20250325","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.gie.2018.10.030","article-title":"Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in China","volume":"89","author":"Yu","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"R33-20250325","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.3748\/wjg.v19.i36.6011","article-title":"Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry","volume":"19","author":"Haidry","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R34-20250325","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.gie.2019.03.017","article-title":"Prospective study of endoscopic focal cryoballoon ablation for esophageal squamous cell neoplasia in China","volume":"90","author":"Ke","year":"2019","journal-title":"Gastrointest Endosc"},{"key":"R35-20250325","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1055\/s-0028-1103414","article-title":"Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC\u2019s of ablative techniques","volume":"40","author":"Dumot","year":"2008","journal-title":"Endoscopy"},{"key":"R36-20250325","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archotol.1997.01900020042006","article-title":"Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin","volume":"123","author":"Savary","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R37-20250325","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.gie.2013.01.014","article-title":"Endotherapy for superficial adenocarcinoma of the esophagus: an American experience","volume":"77","author":"Saligram","year":"2013","journal-title":"Gastrointest Endosc"},{"key":"R38-20250325","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jnci\/90.12.889","article-title":"Photodynamic therapy","volume":"90","author":"Dougherty","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R39-20250325","doi-asserted-by":"crossref","first-page":"22135","DOI":"10.18632\/oncotarget.14029","article-title":"A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer","volume":"8","author":"Yano","year":"2017","journal-title":"Oncotarget"},{"key":"R40-20250325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gie.2010.08.049","article-title":"Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus","volume":"73","author":"Tanaka","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"R41-20250325","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10388-022-00944-3","article-title":"A survey of the clinical outcomes of cervical esophageal carcinoma surgery focusing on the presence or absence of laryngectomy using the National Clinical Database in Japan","volume":"19","author":"Nakajima","year":"2022","journal-title":"Esophagus"},{"key":"R42-20250325","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.athoracsur.2019.04.060","article-title":"Esophagogastric preservation in the surgical management of proximal esophageal cancer","volume":"108","author":"Chow","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R43-20250325","first-page":"1","article-title":"Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer","volume":"30","author":"Takebayashi","year":"2017","journal-title":"Dis Esophagus"},{"key":"R44-20250325","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamaoto.2014.2013","article-title":"Primary radiotherapy compared with primary surgery in cervical esophageal cancer","volume":"140","author":"Cao","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R45-20250325","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1053\/j.gastro.2021.08.007","article-title":"Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma","volume":"161","author":"Kato","year":"2021","journal-title":"Gastroenterology"},{"key":"R46-20250325","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s10388-022-00921-w","article-title":"Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer","volume":"19","author":"Ohno","year":"2022","journal-title":"Esophagus"},{"key":"R47-20250325","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1245\/s10434-018-6648-6","article-title":"Cervical esophageal cancer treatment strategies: a cohort study appraising the debated role of surgery","volume":"25","author":"Valmasoni","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R48-20250325","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ijrobp.2007.10.022","article-title":"Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival","volume":"71","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R49-20250325","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0959-8049(97)00088-9","article-title":"Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer","volume":"33","author":"Bleiberg","year":"1997","journal-title":"Eur J Cancer"},{"key":"R50-20250325","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/COC.0b013e3181aaca26","article-title":"Cisplatin\/Irinotecan versus carboplatin\/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer","volume":"33","author":"Ruppert","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"R51-20250325","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"R52-20250325","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/dote.12110","article-title":"Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma","volume":"27","author":"Blom","year":"2014","journal-title":"Dis Esophagus"},{"key":"R53-20250325","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1200\/JCO.18.02122","article-title":"Comparing paclitaxel plus fluorouracil versus cisplatin plus fluorouracil in chemoradiotherapy for locally advanced esophageal squamous cell cancer: a randomized, multicenter, phase III clinical trial","volume":"37","author":"Chen","year":"2019","journal-title":"J Clin Oncol"},{"key":"R54-20250325","doi-asserted-by":"crossref","first-page":"e220120","DOI":"10.1001\/jamanetworkopen.2022.0120","article-title":"Comparison of 3 paclitaxel-based chemoradiotherapy regimens for patients with locally advanced esophageal squamous cell cancer: a randomized clinical trial","volume":"5","author":"Ai","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R55-20250325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1470-2045(14)70028-2","article-title":"Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5\/ACCORD17): final results of a randomised, phase 2\/3 trial","volume":"15","author":"Conroy","year":"2014","journal-title":"Lancet Oncol"},{"key":"R56-20250325","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1470-2045(13)70096-2","article-title":"Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial","volume":"14","author":"Waddell","year":"2013","journal-title":"Lancet Oncol"},{"key":"R57-20250325","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(13)70136-0","article-title":"Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2\/3 randomised trial","volume":"14","author":"Crosby","year":"2013","journal-title":"Lancet Oncol"},{"key":"R58-20250325","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jamaoncol.2017.1598","article-title":"Effect of the addition of cetuximab to paclitaxel, cisplatin, and radiation therapy for patients with esophageal cancer: the NRG oncology RTOG 0436 phase 3 randomized clinical trial","volume":"3","author":"Suntharalingam","year":"2017","journal-title":"JAMA Oncol"},{"key":"R59-20250325","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41416-023-02388-7","article-title":"Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial","volume":"129","author":"Meng","year":"2023","journal-title":"Br J Cancer"},{"key":"R60-20250325","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2147\/OTT.S50945","article-title":"Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial","volume":"6","author":"Liang","year":"2013","journal-title":"Onco Targets Ther"},{"key":"R61-20250325","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2174\/1568009623666230315145937","article-title":"Efficacy and safety of concurrent chemoradiotherapy combined with nimotuzumab in elderly patients with esophageal squamous cell carcinoma: a prospective real-world pragmatic study","volume":"23","author":"Yu","year":"2023","journal-title":"Curr Cancer Drug Targets"},{"key":"R62-20250325","doi-asserted-by":"crossref","first-page":"905422","DOI":"10.3389\/fonc.2022.905422","article-title":"The application of nimotuzumab combined with definitive chemoradiotherapy toward the treatment of locally advanced cervical esophageal carcinoma: a retrospective study","volume":"12","author":"Hu","year":"2022","journal-title":"Front Oncol"},{"key":"R63-20250325","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"issue":"LBA 4011","key":"R64-20250325","article-title":"Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study","volume":"39","author":"Chau","year":"2021","journal-title":"J Clin Oncol"},{"key":"R65-20250325","doi-asserted-by":"crossref","first-page":"e068714","DOI":"10.1136\/bmj-2021-068714","article-title":"Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial","volume":"377","author":"Lu","year":"2022","journal-title":"BMJ"},{"key":"R66-20250325","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jama.2021.12836","article-title":"Effect of camrelizumab vs placebo added to chemotherapy on survival and progression-free survival in patients with advanced or metastatic esophageal squamous cell carcinoma: the ESCORT-1st randomized clinical trial","volume":"326","author":"Luo","year":"2021","journal-title":"JAMA"},{"key":"R67-20250325","doi-asserted-by":"crossref","first-page":"S1040","DOI":"10.1016\/j.annonc.2021.08.1482","article-title":"JUPITER-06: a randomized, double-blind, phase III study of toripalimab versus placebo in combination with first-line chemotherapy for treatment naive advanced or metastatic esophageal squamous cell carcinoma (ESCC)","volume":"32","author":"Xu","year":"2021","journal-title":"Ann Oncol"},{"key":"R68-20250325","doi-asserted-by":"crossref","first-page":"219","DOI":"10.20892\/j.issn.2095-3941.2019.0268","article-title":"Characterization of 500 Chinese patients with cervical esophageal cancer by clinicopathological and treatment outcomes","volume":"17","author":"Chen","year":"2020","journal-title":"Cancer Biol Med"},{"key":"R69-20250325","article-title":"The clinical outcomes of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a population-based propensity score-matched analysis","volume":"11","author":"Chen","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R70-20250325","article-title":"Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study","volume":"31","author":"Li","year":"2018","journal-title":"Dis Esophagus"},{"key":"R71-20250325","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J Clin Oncol"},{"key":"R72-20250325","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1200\/JCO.20.03697","article-title":"Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study)","volume":"39","author":"Hulshof","year":"2021","journal-title":"J Clin Oncol"},{"key":"R73-20250325","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijrobp.2022.11.006","article-title":"High-dose versus standard-dose intensity-modulated radiotherapy with concurrent paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, phase 3 superiority trial","volume":"115","author":"You","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R74-20250325","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/1078-0432.CCR-21-3843","article-title":"A phase III multicenter randomized clinical trial of 60 Gy versus 50 Gy radiation dose in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma","volume":"28","author":"Xu","year":"2022","journal-title":"Clin Cancer Res"},{"key":"R75-20250325","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ijrobp.2021.07.045","article-title":"Exclusive chemoradiotherapy with or without radiation dose escalation in esophageal cancer: multicenter phase 2\/3 randomized trial CONCORDE (PRODIGE-26)","volume":"111","author":"Crehange","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R76-20250325","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.08.045","article-title":"Multicenter phase 2 study of cisplatin and 5-fluorouracil with concurrent radiation therapy as an organ preservation approach in patients with squamous cell carcinoma of the cervical esophagus","volume":"96","author":"Zenda","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R77-20250325","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00066-021-01894-y","article-title":"Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study","volume":"198","author":"Lan","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"R78-20250325","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13014-018-0957-6","article-title":"Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma","volume":"13","author":"Sakanaka","year":"2018","journal-title":"Radiat Oncol"},{"key":"R79-20250325","doi-asserted-by":"crossref","first-page":"21852","DOI":"10.18632\/oncotarget.15665","article-title":"Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"R80-20250325","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13014-015-0482-9","article-title":"Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study","volume":"10","author":"Yamashita","year":"2015","journal-title":"Radiat Oncol"},{"key":"R81-20250325","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13014-023-02332-2","article-title":"Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes","volume":"18","author":"Wang","year":"2023","journal-title":"Radiat Oncol"},{"key":"R82-20250325","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13014-014-0232-4","article-title":"Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis","volume":"9","author":"Liu","year":"2014","journal-title":"Radiat Oncol"},{"key":"R83-20250325","first-page":"1","article-title":"Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma","volume":"30","author":"Yang","year":"2017","journal-title":"Dis Esophagus"},{"key":"R84-20250325","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.meddos.2015.10.007","article-title":"Dosimetric comparison between step-shoot intensity-modulated radiotherapy and volumetric-modulated arc therapy for upper thoracic and cervical esophageal carcinoma","volume":"41","author":"Gao","year":"2016","journal-title":"Med Dosim"},{"key":"R85-20250325","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.meddos.2022.02.009","article-title":"Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer","volume":"47","author":"Kato","year":"2022","journal-title":"Med Dosim"},{"key":"R86-20250325","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.adro.2020.04.026","article-title":"Acute toxicities and short-term patient outcomes after intensity-modulated proton beam radiation therapy or intensity-modulated photon radiation therapy for esophageal carcinoma: a Mayo clinic experience","volume":"5","author":"Bhangoo","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"R87-20250325","doi-asserted-by":"crossref","first-page":"e2328136","DOI":"10.1001\/jamanetworkopen.2023.28136","article-title":"Efficacy and safety in proton therapy and photon therapy for patients with esophageal cancer: a meta-analysis","volume":"6","author":"Zhou","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R88-20250325","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00066-008-1787-5","article-title":"Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost","volume":"184","author":"Brunner","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"R89-20250325","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0360-3016(99)00253-9","article-title":"Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group","volume":"45","author":"Okawa","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R90-20250325","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ijc.34030","article-title":"Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: a randomized, multicenter, phase II clinical trial","volume":"151","author":"Liu","year":"2022","journal-title":"Int J Cancer"},{"key":"R91-20250325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051220","article-title":"Management of esophageal cancer-associated respiratory-digestive tract fistulas","volume":"14","author":"Grass","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R92-20250325","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MAJ.0000000000000565","article-title":"Airway covered metallic stent based on different fistula location and size in malignant tracheoesophageal fistula","volume":"350","author":"Wang","year":"2015","journal-title":"Am J Med Sci"},{"key":"R93-20250325","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.21037\/jtd-22-138","article-title":"Airway interventions for tracheobronchial involvement in esophageal carcinoma: a retrospective cohort outcome study and algorithmic approach","volume":"14","author":"Leong","year":"2022","journal-title":"J Thorac Dis"},{"key":"R94-20250325","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3748\/wjg.v19.i10.1639","article-title":"Long-term outcomes and prognostic factors for patients with esophageal cancer following radiotherapy","volume":"19","author":"Chen","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R95-20250325","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1091-255X(99)80098-5","article-title":"Serial endoscopic ultrasound in the assessment of response to chemoradiotherapy for carcinoma of the esophagus","volume":"3","author":"Bowrey","year":"1999","journal-title":"J Gastrointest Surg"},{"key":"R96-20250325","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/SLA.0b013e3181a38e9e","article-title":"Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer","volume":"249","author":"Sarkaria","year":"2009","journal-title":"Ann Surg"},{"key":"R97-20250325","first-page":"84","article-title":"Decreased post-treatment SUV on PET Scan is associated with improved local control in medically inoperable esophageal cancer","volume":"4","author":"Sharma","year":"2011","journal-title":"Gastrointest Cancer Res"},{"key":"R98-20250325","first-page":"1845","article-title":"18)F-fluorodeoxyglucose positron emission computed tomography for monitoring tumor response in esophageal carcinoma treated with concurrent chemoradiotherapy","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"R99-20250325","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial","volume":"36","author":"Yang","year":"2018","journal-title":"J Clin Oncol"},{"key":"R100-20250325","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020387","article-title":"Neoadjuvant chemoradiotherapy and larynx-preserving surgery for cervical esophageal cancer","volume":"9","author":"Dai","year":"2020","journal-title":"J Clin Med"},{"key":"R101-20250325","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/1010-7940(93)90248-A","article-title":"Esophageal carcinoma with doubtful extirpability. Value of preoperative chemotherapy plus radiotherapy","volume":"7","author":"Sielezneff","year":"1993","journal-title":"Eur J Cardiothorac Surg"},{"key":"R102-20250325","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doab048","article-title":"Oncological results and morbidity following intended curative resection and free jejunal graft reconstruction of cervical esophageal cancer: a retrospective Danish consecutive cohort study","volume":"35","author":"Erichsen","year":"2022","journal-title":"Dis Esophagus"},{"key":"R103-20250325","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.annonc.2022.10.508","article-title":"Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial","volume":"34","author":"Tang","year":"2023","journal-title":"Ann Oncol"},{"key":"R104-20250325","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00432-021-03659-7","article-title":"Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China","volume":"148","author":"Zhang","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"R105-20250325","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1055\/a-1198-5232","article-title":"Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial","volume":"52","author":"Zhang","year":"2020","journal-title":"Endoscopy"},{"key":"R106-20250325","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/den.14154","article-title":"Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment","volume":"34","author":"Naito","year":"2022","journal-title":"Dig Endosc"},{"key":"R107-20250325","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4251\/wjgo.v14.i9.1758","article-title":"Endoscopic debulking resection with additive chemoradiotherapy: optimal management of advanced inoperable esophageal squamous cell carcinoma","volume":"14","author":"Ren","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"R108-20250325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10388-021-00873-7","article-title":"Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma","volume":"19","author":"Kadota","year":"2022","journal-title":"Esophagus"},{"key":"R109-20250325","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/a-0732-5317","article-title":"Long-term follow-up after endoscopic resection for superficial esophageal squamous cell carcinoma: a multicenter Western study","volume":"51","author":"Berger","year":"2019","journal-title":"Endoscopy"},{"key":"R110-20250325","doi-asserted-by":"crossref","first-page":"959568","DOI":"10.3389\/fsurg.2022.959568","article-title":"Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer","volume":"9","author":"Song","year":"2022","journal-title":"Front Surg"},{"key":"R111-20250325","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4251\/wjgo.v11.i12.1172","article-title":"Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy","volume":"11","author":"Zeng","year":"2019","journal-title":"World J Gastrointest Oncol"},{"key":"R112-20250325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00432-015-2041-z","article-title":"The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma","volume":"142","author":"Chen","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"R113-20250325","first-page":"6881","article-title":"The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma","volume":"8","author":"Ning","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R114-20250325","doi-asserted-by":"crossref","first-page":"483","DOI":"10.21037\/jgo.2019.01.26","article-title":"Adjuvant radiotherapy in oesophageal cancer with positive circumferential resection margins-recurrence and survival outcomes","volume":"10","author":"Vadhwana","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"R115-20250325","doi-asserted-by":"crossref","first-page":"e2151","DOI":"10.1002\/onco.13914","article-title":"Postoperative adjuvant therapy versus surgery alone for stage IIB-III esophageal squamous cell carcinoma: a phase III randomized controlled trial","volume":"26","author":"Ni","year":"2021","journal-title":"Oncologist"},{"key":"R116-20250325","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1634\/theoncologist.2019-0276","article-title":"Postoperative radiotherapy in pathological T2-3N0M0 thoracic esophageal squamous cell carcinoma: interim report of a prospective, phase III, randomized controlled study","volume":"25","author":"Deng","year":"2020","journal-title":"Oncologist"},{"key":"R117-20250325","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13014-020-01557-9","article-title":"Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis","volume":"15","author":"Wang","year":"2020","journal-title":"Radiat Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000001165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T08:45:06Z","timestamp":1743151506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000001165"}},"subtitle":["Systematic Review and Guidelines"],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000001165","relation":{},"ISSN":["0277-3732","1537-453X"],"issn-type":[{"value":"0277-3732","type":"print"},{"value":"1537-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}